| ConoServer: updated content, knowledge, and discovery tools in the conopeptide database Q Kaas, R Yu, AH Jin, S Dutertre, DJ Craik Nucleic acids research 40 (D1), D325-D330, 2012 | 407 | 2012 |
| Pathophysiology of obesity and its associated diseases X Jin, T Qiu, L Li, R Yu, X Chen, C Li, CG Proud, T Jiang Acta Pharmaceutica Sinica B 13 (6), 2403-2424, 2023 | 233 | 2023 |
| SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells Y Tong, D Guo, SH Lin, J Liang, D Yang, C Ma, F Shao, M Li, Q Yu, ... Molecular cell 81 (11), 2303-2316. e8, 2021 | 126 | 2021 |
| Determination of the α-conotoxin Vc1. 1 binding site on the α9α10 nicotinic acetylcholine receptor R Yu, SN Kompella, DJ Adams, DJ Craik, Q Kaas Journal of medicinal chemistry 56 (9), 3557-3567, 2013 | 108 | 2013 |
| Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets R Liu, JH Lee, J Li, R Yu, L Tan, Y Xia, Y Zheng, XL Bian, PL Lorenzi, ... Molecular cell 81 (13), 2722-2735. e9, 2021 | 99 | 2021 |
| Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations R Yu, DJ Craik, Q Kaas PLoS computational biology 7 (3), e1002011, 2011 | 91 | 2011 |
| Less is more: design of a highly stable disulfide-deleted mutant of analgesic cyclic α-conotoxin Vc1. 1 R Yu, VAL Seymour, G Berecki, X Jia, M Akcan, DJ Adams, Q Kaas, ... Scientific reports 5 (1), 13264, 2015 | 59 | 2015 |
| Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4 Z Yu, W Sun, W Peng, R Yu, G Li, T Jiang Molecular Pharmaceutics 13 (5), 1699-1710, 2016 | 55 | 2016 |
| Designing antimicrobial peptides using deep learning and molecular dynamic simulations Q Cao, C Ge, X Wang, PJ Harvey, Z Zhang, Y Ma, X Wang, X Jia, M Mobli, ... Briefings in Bioinformatics 24 (2), bbad058, 2023 | 53 | 2023 |
| Novel natural angiotensin converting enzyme (ACE)-inhibitory peptides derived from sea cucumber-modified hydrolysates by adding exogenous proline and a study of their structure … J Li, Z Liu, Y Zhao, X Zhu, R Yu, S Dong, H Wu Marine Drugs 16 (8), 271, 2018 | 52 | 2018 |
| Agonist and antagonist binding in human glycine receptors R Yu, E Hurdiss, T Greiner, R Lape, L Sivilotti, PC Biggin Biochemistry 53 (38), 6041-6051, 2014 | 46 | 2014 |
| Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor X Li, HS Tae, Y Chu, T Jiang, DJ Adams, R Yu Pharmacology & therapeutics 222, 107792, 2021 | 45 | 2021 |
| Cyclic analogues of α‐conotoxin Vc1. 1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain J Castro, L Grundy, A Deiteren, AM Harrington, T O'Donnell, J Maddern, ... British Journal of Pharmacology 175 (12), 2384-2398, 2018 | 44 | 2018 |
| Progress in developing MNK inhibitors X Jin, R Yu, X Wang, CG Proud, T Jiang European Journal of Medicinal Chemistry 219, 113420, 2021 | 40 | 2021 |
| Delineation of the unbinding pathway of α-conotoxin ImI from the α7 nicotinic acetylcholine receptor R Yu, Q Kaas, DJ Craik The Journal of Physical Chemistry B 116 (21), 6097-6105, 2012 | 39 | 2012 |
| Boronic acid modifications enhance the anti-influenza A virus activities of novel quindoline derivatives W Wang, R Yin, M Zhang, R Yu, C Hao, L Zhang, T Jiang Journal of Medicinal Chemistry 60 (7), 2840-2852, 2017 | 37 | 2017 |
| Fructose-1, 6-bisphosphatase 1 functions as a protein phosphatase to dephosphorylate histone H3 and suppresses PPARα-regulated gene transcription and tumour growth Z Wang, M Li, H Jiang, S Luo, F Shao, Y Xia, M Yang, X Ren, T Liu, M Yan, ... Nature cell biology 24 (11), 1655-1665, 2022 | 36 | 2022 |
| Application of reverse docking for target prediction of marine compounds with anti-tumor activity F Chen, Z Wang, C Wang, Q Xu, J Liang, X Xu, J Yang, C Wang, T Jiang, ... Journal of Molecular Graphics and Modelling 77, 372-377, 2017 | 36 | 2017 |
| Discovery of DNA topoisomerase I inhibitors with low-cytotoxicity based on virtual screening from natural products LT Xin, L Liu, CL Shao, RL Yu, FL Chen, SJ Yue, M Wang, ZL Guo, ... Marine drugs 15 (7), 217, 2017 | 36 | 2017 |
| Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening L Zhang, H Zhao, J Liu, L He, R Yu, C Kang Future Medicinal Chemistry 14 (6), 393-405, 2022 | 35 | 2022 |
David J. AdamsDistinguished Professor, University of Wollongong, Illawarra Health & Medical ResearchПотвърден имейл адрес: uow.edu.au